PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

HDL cholesterol controls blood glucose

2013-10-30
(Press-News.org) Contact information: Dr. Susanna Hofmann
susanna.hofmann@helmholtz-muenchen.de
49-893-187-2112
Helmholtz Zentrum München - German Research Center for Environmental Health
HDL cholesterol controls blood glucose Atherosclerotic cardiovascular disease rates are markedly increased in individuals with type 2 diabetes. One of the strongest independent predictors of cardiovascular disease in these patients is a low circulating level of high density lipoprotein (HDL) cholesterol and its major protein constituent apolipoprotein A-I (ApoA-I). An international team of scientists led by Dr. Susanna Hofmann from the Institute of Diabetes and Regeneration Research at the Helmholtz Zentrum München (HMGU), Partner of the German Center for Diabetes Research (DZD), and Dr. Maarit Lehti from the LIKES Research Center for Sport and Health Sciences, Jyväskylä, Finland, have now determined that normal circulating HDL levels are required for proper skeletal muscle metabolism and function.

In their study, Hofmann and her team observed that without ApoA-I, burning of calories is reduced in skeletal muscle resulting in increased blood glucose and weaker muscle function. The scientists then determined that HDL cholesterol and its protein ApoA-I both enhance usage of glucose and calories inside muscle cells. Raising HDL and ApoA-I levels in animal models resulted in protection against hyperglycemia and age-related symptoms such as decline of muscle performance or fat mass gain. Improved calorie burning in mitochondria (the "power plants" in each cell) was further indicated by a marked reduction of circulating Fibroblast Growth Factor 21, a novel biomarker for mitochondrial dysfunction.

"Our results link for the first time low HDL-cholesterol with impaired use of glucose and burning of calories in type 2 diabetes. ApoA-I analogues are now clinically tested for the prevention and regression of atherosclerosis. Based on our findings described herein, these analogs may offer underappreciated potential for therapeutic opportunities in diabetes", explains Hofmann, who investigates interactions of fat and glucose metabolism with her international team. She adds: "Most importantly, our results are highly relevant for women with type 2 diabetes. Their risk for cardiovascular diseases compared to men with type 2 diabetes is significantly increased, because these women have low concentrations of HDL-cholesterol and ApoA-I."

The numerous conditions associated with overweight and obesity, such as T2D, are among the major widespread diseases in Germany. They are the focus of the research at the Helmholtz Zentrum München.

### Further Information

Original publication:

Lehti, M. et al (2013). High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice, Circulation, doi: 10.1161/CIRCULATIONAHA.113.001551

Link to publication

As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,100 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 34,000 staff members.http://www.helmholtz-muenchen.de

The German Center for Diabetes Research (DZD) brings together experts in the field of diabetes research and interlinks basic research, epidemiology and clinical applications. Members are the German Diabetes Center in Düsseldorf, the German Institute of Human Nutrition (DIfE) in Potsdam-Rehbrücke, Helmholtz Zentrum München – German Research Center for Environmental Health, the Paul Langerhans Institutes of the University Hospital Carl Gustav Carus in Dresden and the University of Tübingen, as well as the Gottfried Wilhelm Leibniz Association and the Helmholtz Association of German Research Centres. The objective of the DZD is to find answers to open questions in diabetes research by means of a novel, integrative research approach and to make a significant contribution to improving the prevention, diagnosis and treatment of diabetes mellitus.

Contact for the media

Communication Department, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg -Phone: +49-89-3187-2238 - Fax: 089-3187-3324 - E-Mail: presse@helmholtz-muenchen.de

Scientific contact

Dr. Susanna Hofmann, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Institute of Diabetes and Regeneration Research, Ingolstädter Landstr. 1, 85764 Neuherberg -Phone: +49-89-3187-2112 - E-Mail: susanna.hofmann@helmholtz-muenchen.de


ELSE PRESS RELEASES FROM THIS DATE:

Brain regions can be specifically trained

2013-10-30
Brain regions can be specifically trained This news release is available in German. Video gaming causes increases in the brain regions responsible for spatial orientation, memory formation and strategic planning as well as fine motor skills. This ...

The world's most powerful terahertz quantum cascade laser

2013-10-30
The world's most powerful terahertz quantum cascade laser Whether it is diagnostic imaging, analysis of unknown substances or ultrafast communication -- terahertz radiation sources are becoming more and more important; At the Vienna University ...

Google street view -- tool for recording earthquake damage

2013-10-30
Google street view -- tool for recording earthquake damage 2009 L'Aquila quake's destruction revealed through contrast of images SAN FRANCISCO, October 30, 2013 -- A scientist from Cologne University has used Google's online street view scans to document ...

A mimic of 'good cholesterol' could someday treat cardiovascular and other diseases

2013-10-30
A mimic of 'good cholesterol' could someday treat cardiovascular and other diseases A new type of "good cholesterol," made in the lab, could one day deliver drugs to where they are needed in the body to treat disease or be used in medical imaging, according ...

Low vitamin D levels during pregnancy associated with preterm birth in non-white mothers

2013-10-30
Low vitamin D levels during pregnancy associated with preterm birth in non-white mothers PITTSBURGH, Oct. 30, 2013 – African-American and Puerto Rican women who have low levels of vitamin D during pregnancy are more likely to go ...

Baking blueberries changes their polyphenol content -- and possibly their health benefits

2013-10-30
Baking blueberries changes their polyphenol content -- and possibly their health benefits Blueberries are called a "superfood" for their high polyphenol content, but when served as warm, gooey pie filling or when lending bursts of sweet flavor to a muffin, ...

Historic blaze fueled a boom in tire recycling, advances in fire monitoring

2013-10-30
Historic blaze fueled a boom in tire recycling, advances in fire monitoring An historic tire fire 30 years ago that blazed on for nine months in the northwest Virginia Appalachians, releasing giant plumes of toxic smoke, sparked a recycling revolution and ...

Novel technique for suturing tissue-engineered collagen graft improves tendon repair

2013-10-30
Novel technique for suturing tissue-engineered collagen graft improves tendon repair New Rochelle, NY, October 30, 2013—The repair of ruptured tendons often requires the use of a graft to bridge gaps between the torn tendon and ...

Bloomberg's health legacy: Urban innovator or meddling nanny?

2013-10-30
Bloomberg's health legacy: Urban innovator or meddling nanny? Outgoing New York City mayor 'has fundamentally changed public health policy discourse,' says bioethics leader (Garrison, NY) As New York City Mayor Michael Bloomberg prepares to leave office, ...

Alarming increasing incidence of myopia

2013-10-30
Alarming increasing incidence of myopia New findings reveal environmental factors are an important influence on the development and progression of myopia -- special issue of Optometry and Vision Science highlights research advances in myopia Philadelphia, ...

LAST 30 PRESS RELEASES:

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

[Press-News.org] HDL cholesterol controls blood glucose